DVCR Diversicare Healthcare Services Inc

Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care services, today announced its results for the third quarter ended September 30, 2020.

Third Quarter 2020 Highlights

• Net income from continuing operations was $3.2 million, or $0.48 per share, in the third quarter of 2020, compared to net loss from continuing operations of $(1.9) million, or $(0.30) per share, in the third quarter of 2019.
• EBITDA for the quarter was $6.7 million, which was $5.5 million higher than the third quarter of 2019 and $1.2 million higher than the preceding quarter.
• EBITDAR for the quarter was $20.2 million.

See below for a reconciliation of all GAAP and non-GAAP financial results.

CEO Remarks

Commenting on the quarter, Jay McKnight, President and Chief Executive Officer, said, “Despite the impact of the COVID-19 pandemic continuing to challenge our company, this quarter the Diversicare team performed exceptionally well operationally and continued to realize financial gains from cost saving initiatives made during the prior year. The regional and local teams have heroically cared for our patients and residents while dealing with COVID-19 cases in all of our 62 centers at some point during the pandemic. We are so proud of the accomplishments and improvements made by our team in this constantly changing regulatory environment.”

Mr. McKnight continued, "Earlier this week we announced a new partnership with Reliant Rehabilitation to be our therapy provider in all of our centers. We believe that this transition will equip us to continue to be a care innovator and ensure that we can provide the best quality of care to our patients and residents. We also expect cost savings from efficiencies gained by this new relationship. This is one of many ways we are striving to continue improving our company so that we will come out of the pandemic better prepared to be an industry leader and high quality provider.”

COVID-19 Update

We have received federal support by way of stimulus grants totaling $42.3 million that must be used to offset lost revenue or excess expenses incurred to fight COVID-19. Several of our states have temporarily increased our Medicaid rates to assist with the costs of dealing with the pandemic. We anticipate that we will incur significant expense and lost revenue in the fourth quarter and beyond related to fighting this disease.

The CDC and Centers for Medicare and Medicaid Services (“CMS”) has continued to expand reporting guidelines for our centers to follow. Reporting guidance requires notifying residents and designated representatives of the occurrence of a single confirmed COVID-19 positive case, any subsequent positive cases, any COVID-19 positive new admission, and/or three or more cases of new onset respiratory symptoms occurring within 72 hours. Our centers remain compliant with regular reporting to the CDC and CMS regarding the number of COVID-19 cases in our centers, patient deaths, and other information. This information is reported in accordance with existing privacy regulations and statues for the safety and well-being of our residents.

The CDC has recently announced the addition of Point of Care (“POC”) Test Reporting that will charge our centers with the responsibility of reporting comprehensive test result data on a reoccurring basis. The frequency of reporting will vary by center as it is determined by the center’s COVID-19 status and community positivity rate.

We are committed to keeping our residents and their designated representatives informed as we continue to navigate COVID-19 in our centers. We will continue to report aggregated COVID-19 data for the company our website at https://dvcr.com/our-response-to-covid-19/ and provide center specific information on each of our center’s websites.

Third Quarter 2020 Results

The following table summarizes key revenue and census statistics for continuing operations for each period:

 

Three Months Ended September 30,

 

2020

 

 

 

2019

Skilled nursing occupancy

66.7

%

 

 

 

77.6

%

As a percent of total census:

 

 

 

 

 

Medicare census

11.7

%

 

 

 

8.9

%

Medicaid census

66.3

%

 

 

 

69.9

%

Managed Care census

4.8

%

 

 

 

4.4

%

As a percent of total revenues:

 

 

 

 

 

Medicare revenues

20.7

%

 

 

 

16.2

%

Medicaid revenues

47.3

%

 

 

 

48.2

%

Managed Care revenues

10.1

%

 

 

 

9.9

%

*Average rate per day:

 

 

 

 

 

Medicare

$

503.75

 

 

 

 

$

454.52

 

Medicaid

$

183.27

 

 

 

 

$

178.35

 

Managed Care

$

430.88

 

 

 

 

$

389.69

 

 

 

 

 

 

 

*Excludes COVID-19 stimulus payments

 

 

 

 

 

Patient revenues were $118.0 million and $118.6 million for the three months ended September 30, 2020 and 2019, respectively, a decrease of $0.6 million.

Our Medicaid, Medicare and Managed Care rates for the third quarter of 2020 increased 2.8%, 10.8% and 10.6%, respectively, resulting in a revenue increase of $1.5 million, $1.9 million and $0.9 million, respectively. Our Medicaid, Private, Managed Care and Hospice average daily census for the third quarter of 2020 decreased 18.4%, 16.7%, 4.8% and 5.5%, respectively, resulting in lost revenue of $12.0 million, $1.4 million, $0.4 million and $0.5 million, respectively. Our Medicare census for the third quarter of 2020 increased 13.2% resulting in increased revenue of $2.8 million. The decline in census for the third quarter of 2020 was mainly due to the impact of the COVID-19 pandemic. We recognized $6.6 million Medicaid state stimulus funds during the third quarter of 2020. Additionally, the suspension of sequestration for the third quarter of 2020 resulted in an increase in revenue of $0.7 million.

During the nine month period ended September 30, 2020, we received $42.3 million of provider relief from the Public Health and Social Services Emergency Fund. We recognized $9.6 million of the funds during the third quarter of 2020, which is classified as "Other Operating Income" in the Company's results of operations for the three month period ended September 30, 2020. The Medicare stimulus funds that we recognized during the quarter were used to offset healthcare-related expenses and lost revenues attributable to COVID-19. Increased healthcare related expenses included but were not limited to increased wages and increased costs for personal protective equipment, testing and other supplies.

Operating expense increased in the third quarter of 2020 to $98.7 million from $95.6 million in the third quarter of 2019, an increase of $3.1 million. Operating expense increased as a percentage of patient revenues to 83.7% for the third quarter of 2020 as compared to 80.6% for the third quarter of 2019.

The primary driver for the increase in operating expense was COVID-19 related expenses of $12.7 million. COVID-19 expenses included increased wages and increased cost for personal protective equipment, testing, food and certain other supplies. Excluding COVID-19, we benefited from our cost saving initiatives including decreased wages of $5.4 million to $52.8 million in the third quarter of 2020, compared to $58.2 million in the third quarter of 2019. Additionally, our nursing and ancillary and health insurance costs decreased by $1.8 million and $1.4 million, respectively.

Lease expense in the third quarter of 2020 increased to $13.5 million as compared to $13.3 million in the third quarter of 2019, an increase of $0.2 million. The increase in lease expense was due to rent increases resulting from the amendment to the Lease with Omega Healthcare Investors in conjunction with the Kentucky Exit.

Professional liability expense was $2.2 million and $1.7 million in the third quarters of 2020 and 2019, respectively. Our cash expenditures for professional liability costs, including those relative to claims for the centers that we formerly operated in the State of Kentucky, were $1.8 million and $1.9 million for the third quarters of 2020 and 2019, respectively. Professional liability expense fluctuates based on the results of our third-party professional liability actuarial studies, premiums and cash expenditures are incurred to defend and settle existing claims.

General and administrative expense was $6.5 million for the third quarter of 2020 compared to $6.9 million for the third quarter of 2019, a decrease of $0.4 million or 6.0%.

Depreciation and amortization expense decreased to $2.1 million for the third quarter of 2020 compared to $2.3 million in the third quarter of 2019.

Interest expense was $1.2 million in the third quarter of 2020 and $1.6 million in the third quarter of 2019. The decrease of $0.4 million was due to a decrease in the outstanding borrowings on our loan facilities.

The Company recorded income tax provision for continuing operations of $0.2 million and income tax benefit of $0.7 million during the third quarters of 2020 and 2019, respectively.

As a result of the above, continuing operations reported income of $3.4 million before income taxes for the third quarter of 2020 as compared to a loss of $2.7 million for the third quarter of 2019. Both basic and diluted income per common share from continuing operations were $0.48 for the third quarter of 2020 as compared to both basic and diluted loss per common share from continuing operations of $0.30 in the third quarter of 2019.

COVID-19 Impact on Continuing Operations

Since the end of the quarter, there have been additional cases of COVID-19 at certain of our centers. The Company has continued to experience reduced occupancy and increased operating expenses at its centers in the form of increased wages and increased cost for personal protective equipment, food and certain other supplies. The Company expects such increased expenses to continue and likely increase further during the remainder of 2020.

Receivables

Our net receivables balance decreased $9.9 million to $50.6 million as of September 30, 2020, from $60.5 million as of December 31, 2019.

Conference Call Information

A conference call has been scheduled for Thursday, November 5, 2020 at 4:00 P.M. Central time (5:00 P.M. Eastern time) to discuss third quarter 2020 results. The conference call information is as follows:

Date:

 

Thursday, November 5, 2020

Time:

 

4:00 P.M. Central, 5:00 P.M. Eastern

Webcast Links:

 

www.DVCR.com

Dial in numbers:

 

800.954.1051

Access Code: 21971704

The Operator will connect you to Diversicare’s Conference Call.

A replay of the conference call will be accessible two hours after its completion through November 12, 2020, by dialing 800-633-8284 and entering Access Code: 21971704.

FORWARD-LOOKING STATEMENTS

The “forward-looking statements” contained in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. These forward-looking statements reflect our current views with respect to future events and present our estimates and assumptions only as of the date of this release. Actual results could differ materially from those contemplated by the forward-looking statements made in this release. In addition to any assumptions and other factors referred to specifically in connection with such statements, other factors, many of which are beyond our ability to control or predict, could cause our actual results to differ materially from the results expressed or implied in any forward-looking statements including, but not limited to, the potential adverse effect of the COVID-19 pandemic on the economy, our patients and residents and supply chain, including, changes in the occupancy of our centers, increased operation costs in addressing COVID-19, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operations challenges faced by its patients served, the duration and severity of the COVID-19 pandemic and the extent and severity of the impact on the Company's patients and residents, actions governments take in response to the COVID-19 pandemic, including the introduction of public health measures and other regulations affecting our centers, the impact of the CARES Act, the Paycheck Protection Program and Health Care Enhancement Act and any other COVID-19 relief aid adopted by governments or the implementation or modifications to such acts, including any obligation of the Company to repay any stimulus payments received under such relief aid, perceptions regarding the safety of senior living communities during and after the pandemic, changes in demand for senior living communities and our ability to adapt our sales and marketing efforts to meet the demand, changes in the acuity levels of our new residents, the disproportionate impact of COVID-19 on seniors generally and those residing in our communities, increased regulatory requirements, including unfunded mandatory testing, increased enforcement actions resulting from COVID-19, including those that may limit our collection efforts for delinquent accounts and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or our response efforts, our ability to successfully integrate the operations of new nursing centers, as well as successfully operate all of our centers, our ability to increase census at our centers and occupancy rates at our centers, changes in governmental reimbursement, including the new Patient-Driven Payment Model that was implemented in October of 2019, government regulation, the impact of the Affordable Care Act, efforts to repeal or further modify the Affordable Care Act, and other health care reform initiatives, any increases in the cost of borrowing under our credit agreements, our ability to comply with covenants contained in those credit agreements, our ability to comply with the terms of our master lease agreements, our ability to renew or extend our leases at or prior to the end of the existing lease terms, the outcome of professional liability lawsuits and claims, our ability to control ultimate professional liability costs, the accuracy of our estimate of our anticipated professional liability expense, the impact of future licensing surveys, the outcome of proceedings alleging violations of state or Federal False Claims Acts, laws and regulations governing quality of care or other laws and regulations applicable to our business including HIPAA and laws governing reimbursement from government payors, the costs of investing in our business initiatives and development, our ability to control costs, our ability to attract and retain qualified healthcare professionals, changes to our valuation of deferred tax assets, changing economic and competitive conditions, changes in anticipated revenue and cost growth, changes in the anticipated results of operations, the effect of changes in accounting policies as well as others.

The Company has provided additional information in its Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as well as in its other filings with the Securities and Exchange Commission, which readers are encouraged to review for further disclosure of other factors. These assumptions may not materialize to the extent assumed, and risks and uncertainties may cause actual results to be different from anticipated results. These risks and uncertainties also may result in changes to the Company’s business plans and prospects. Diversicare Healthcare Services, Inc. is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

Diversicare provides long-term care services to patients in 62 nursing centers and 7,329 skilled nursing beds. For additional information about the Company, visit Diversicare's web site: www.DVCR.com.

-Financial Tables to Follow-

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

 

 

 

 

 

 

September 30, 2020

 

December 31, 2019

 

 

(Unaudited)

 

 

ASSETS:

 

 

 

 

Current Assets

 

 

 

 

Cash

 

$

30,223

 

 

$

2,710

 

Receivables

 

 

50,593

 

 

 

60,521

 

Self-insurance receivables, current portion

 

 

685

 

 

 

1,011

 

Supplies

 

 

4,165

 

 

 

710

 

Other current assets

 

 

9,252

 

 

 

7,364

 

Total current assets

 

 

94,918

 

 

 

72,316

 

 

 

 

 

 

Property and equipment, net

 

 

44,588

 

 

 

47,755

 

Acquired leasehold interest, net

 

 

5,336

 

 

 

5,736

 

Operating lease assets

 

 

290,508

 

 

 

310,238

 

Other assets

 

 

3,450

 

 

 

4,323

 

TOTAL ASSETS

 

$

438,800

 

 

$

440,368

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' DEFICIT:

 

 

 

 

Current Liabilities

 

 

 

 

Current portion of long-term debt and finance lease obligations

 

$

1,516

 

 

$

3,498

 

Trade accounts payable

 

 

10,402

 

 

 

14,641

 

Current portion of operating lease liabilities

 

 

26,217

 

 

 

23,736

 

Accrued expenses:

 

 

 

 

Payroll and employee benefits

 

 

19,644

 

 

 

16,780

 

Current portion of self-insurance reserves

 

 

12,793

 

 

 

13,829

 

Deferred income

 

 

27,157

 

 

 

—

 

Other current liabilities

 

 

14,631

 

 

 

11,545

 

Total current liabilities

 

 

112,360

 

 

 

84,029

 

Noncurrent Liabilities

 

 

 

 

Long-term debt and finance lease obligations, less current portion and deferred financing costs, net

 

 

57,810

 

 

 

70,637

 

Operating lease liabilities, less current portion

 

 

275,909

 

 

 

295,636

 

Self-insurance reserves, less current portion

 

 

15,798

 

 

 

16,291

 

Government settlement accrual

 

 

8,000

 

 

 

9,000

 

Other noncurrent liabilities

 

 

1,961

 

 

 

1,691

 

Total noncurrent liabilities

 

 

359,478

 

 

 

393,255

 

 

 

 

 

 

SHAREHOLDERS’ DEFICIT

 

 

(33,038

)

 

 

(36,916

)

 

 

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT

 

$

438,800

 

 

$

440,368

 

 

 

 

 

 

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

 

 

Three Months Ended September 30,

 

2020

 

2019

PATIENT REVENUES, NET

$

117,965

 

 

$

118,630

 

OTHER OPERATING INCOME

 

9,563

 

 

 

—

 

OPERATING EXPENSE

 

98,706

 

 

 

95,591

 

Facility-level operating income

 

28,822

 

 

 

23,039

 

 

 

 

 

EXPENSES:

 

 

 

Lease and rent expense

 

13,524

 

 

 

13,251

 

Professional liability

 

2,249

 

 

 

1,737

 

General and administrative

 

6,487

 

 

 

6,902

 

Depreciation and amortization

 

2,098

 

 

 

2,279

 

Total expenses less operating

 

24,358

 

 

 

24,169

 

OPERATING INCOME (LOSS)

 

4,464

 

 

 

(1,130

)

OTHER INCOME (EXPENSE):

 

 

 

Interest expense, net

 

(1,172

)

 

 

(1,554

)

Other income

 

90

 

 

 

25

 

Total other expense

 

(1,082

)

 

 

(1,529

)

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

3,382

 

 

 

(2,659

)

BENEFIT (PROVISION) FOR INCOME TAXES

 

(209

)

 

 

741

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

3,173

 

 

 

(1,918

)

LOSS FROM DISCONTINUED OPERATIONS

 

(374

)

 

 

(2,956

)

NET INCOME (LOSS)

$

2,799

 

 

$

(4,874

)

 

 

 

 

NET INCOME (LOSS) PER COMMON SHARE:

 

 

 

Per common share – basic

 

 

 

Continuing operations

$

0.48

 

 

$

(0.30

)

Discontinued operations

 

(0.06

)

 

 

(0.45

)

 

$

0.42

 

 

$

(0.75

)

Per common share – diluted

 

 

 

Continuing operations

$

0.48

 

 

$

(0.30

)

Discontinued operations

 

(0.06

)

 

 

(0.45

)

 

$

0.42

 

 

$

(0.75

)

 

 

 

 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:

 

 

 

Basic

 

6,577

 

 

 

6,470

 

Diluted

 

6,626

 

 

 

6,470

 

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

 

 

 

 

 

Nine Months Ended September 30,

 

 

2020

 

2019

PATIENT REVENUES, NET

$

356,195

 

 

$

354,145

 

OTHER OPERATING INCOME

 

14,711

 

 

 

—

 

OPERATING EXPENSE

 

289,340

 

 

 

284,643

 

Facility-level operating income

 

81,566

 

 

 

69,502

 

 

 

 

 

EXPENSES:

 

 

 

Lease and rent expense

 

40,560

 

 

 

39,480

 

Professional liability

 

6,202

 

 

 

5,182

 

Government settlement expense

 

—

 

 

 

3,100

 

General and administrative

 

20,125

 

 

 

21,267

 

Depreciation and amortization

 

6,663

 

 

 

6,812

 

Total expenses less operating

 

73,550

 

 

 

75,841

 

OPERATING INCOME (LOSS)

 

8,016

 

 

 

(6,339

)

OTHER INCOME (EXPENSE):

 

 

 

Interest expense, net

 

(3,841

)

 

 

(4,424

)

Other income

 

614

 

 

 

207

 

Total other expense

 

(3,227

)

 

 

(4,217

)

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

4,789

 

 

 

(10,556

)

PROVISION FOR INCOME TAXES

 

(287

)

 

 

(15,544

)

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

4,502

 

 

 

(26,100

)

LOSS FROM DISCONTINUED OPERATIONS

 

(1,004

)

 

 

(6,716

)

NET INCOME (LOSS)

$

3,498

 

 

$

(32,816

)

 

 

 

 

NET INCOME (LOSS) PER COMMON SHARE:

 

 

 

Per common share – basic

 

 

 

Continuing operations

$

0.68

 

 

$

(4.04

)

Discontinued operations

 

(0.15

)

 

 

(1.04

)

 

$

0.53

 

 

$

(5.08

)

Per common share – diluted

 

 

 

Continuing operations

$

0.67

 

 

$

(4.04

)

Discontinued operations

 

(0.15

)

 

 

(1.04

)

 

$

0.52

 

 

$

(5.08

)

 

 

 

 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:

 

 

 

Basic

 

6,606

 

 

 

6,455

 

Diluted

 

6,676

 

 

 

6,455

 

DIVERSICARE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

 

 

Nine Months Ended September 30,

 

 

2020

 

2019

NET INCOME (LOSS)

$

3,498

 

 

$

(32,816

)

Discontinued operations

 

(1,004

)

 

 

(6,716

)

Net income (loss) from continuing operations

 

4,502

 

 

 

(26,100

)

Adjustments to reconcile net income (loss) from continuing operations to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

6,663

 

 

 

6,812

 

Deferred income tax benefit

 

—

 

 

 

15,851

 

Provision for self-insured professional liability, net of cash payments

 

1,066

 

 

 

4,682

 

Amortization of right-of-use assets

 

17,253

 

 

 

15,631

 

Government settlement expense

 

—

 

 

 

3,100

 

Stock based compensation

 

491

 

 

 

429

 

Provision for leases in excess of cash payments

 

2,477

 

 

 

3,768

 

Other

 

959

 

 

 

643

 

Changes in assets and liabilities affecting operating activities:

 

 

 

Receivables

 

10,254

 

 

 

7,024

 

Prepaid expenses and other assets

 

(6,029

)

 

 

(4,071

)

Trade accounts payable and accrued expenses

 

(518

)

 

 

(3,447

)

Deferred income

 

27,157

 

 

 

—

 

Operating lease liabilities

 

(17,246

)

 

 

(15,635

)

Cash provided by operating activities from continuing operations

 

47,029

 

 

 

8,687

 

Cash used in operating activities from discontinued operations

 

(1,004

)

 

 

(5,130

)

Cash provided by operating activities

 

46,025

 

 

 

3,557

 

 

 

 

 

Cash used in investing activities from continuing operations

 

(3,994

)

 

 

(3,745

)

Cash provided by investing activities from discontinued operations

 

—

 

 

 

6

 

Cash used in investing activities

 

(3,994

)

 

 

(3,739

)

 

 

 

 

Cash provided by (used in) financing activities

 

(14,518

)

 

 

1,437

 

 

 

 

 

Net increase in cash

 

27,513

 

 

 

1,255

 

Cash beginning of period

 

2,710

 

 

 

2,685

 

Cash end of period

$

30,223

 

 

$

3,940

 

DIVERSICARE HEALTHCARE SERVICES, INC.

RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND EBITDAR

(In thousands)

 

 

 

 

 

For Three Months Ended

 

 

September 30, 2020

 

June 30, 2020

 

March 31, 2020

 

December 31, 2019

 

September 30, 2019

 

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

Net income (loss)

 

$

2,799

 

$

1,452

 

$

(753

)

 

$

(3,247

)

 

$

(4,874

)

Loss from discontinued operations, net of tax

 

 

374

 

 

387

 

 

243

 

 

 

1,879

 

 

 

2,956

 

Income tax provision (benefit)

 

 

209

 

 

182

 

 

(104

)

 

 

150

 

 

 

(741

)

Interest expense

 

 

1,172

 

 

1,209

 

 

1,460

 

 

 

1,570

 

 

 

1,554

 

Depreciation and amortization

 

 

2,098

 

 

2,278

 

 

2,288

 

 

 

2,310

 

 

 

2,279

 

EBITDA

 

 

6,652

 

 

5,508

 

 

3,134

 

 

 

2,662

 

 

 

1,174

 

 

 

 

 

 

 

 

 

 

 

 

Lease expense (a)

 

$

13,524

 

$

13,523

 

$

13,512

 

 

$

13,510

 

 

$

13,251

 

(a)

As management, we evaluate EBITDA exclusive of lease expense, or EBITDAR, as a financial valuation metric. For the three month period ended September 30, 2020, EBITDAR is calculated below.

EBITDA

$

6,652

Lease expense

$

13,524

EBITDAR

$

20,176

DIVERSICARE HEALTHCARE SERVICES, INC.

RECONCILIATION OF NET INCOME (LOSS) FOR DIVERSICARE HEALTHCARE

SERVICES, INC. COMMON SHAREHOLDERS TO NET INCOME (LOSS) FROM CONTINUING OPERATIONS

FOR DIVERSICARE HEALTHCARE SERVICES, INC. COMMON SHAREHOLDERS

(In thousands, except per share data)

 

 

 

 

 

For Three Months Ended

 

 

September 30, 2020

 

June 30, 2020

 

March 31, 2020

 

December 31, 2019

 

September 30, 2019

 

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

 

(Unaudited)

Net income (loss)

 

$

2,799

 

$

1,452

 

$

(753

)

 

$

(3,247

)

 

$

(4,874

)

Adjustments:

 

 

 

 

 

 

 

 

 

 

Discontinued operations, net of tax

 

 

374

 

 

387

 

 

243

 

 

 

1,879

 

 

 

295

 

Net income (loss) from continuing operations

 

$

3,173

 

$

1,839

 

$

(510

)

 

$

(1,368

)

 

$

(4,579

)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations per common share

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.48

 

$

0.28

 

$

(0.08

)

 

$

(0.22

)

 

$

(0.71

)

Diluted

 

$

0.48

 

$

0.28

 

$

(0.08

)

 

$

(0.22

)

 

$

(0.71

)

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:

 

 

 

 

 

 

 

 

 

 

Basic

 

 

6,577

 

 

6,649

 

 

6,506

 

 

 

6,471

 

 

 

6,470

 

Diluted

 

 

6,626

 

 

6,704

 

 

6,506

 

 

 

6,471

 

 

 

6,470

 

 

 

 

 

 

 

 

 

 

 

 

We have included certain financial performance and valuation measures in this press release, including EBITDA and EBITDAR which are “non-GAAP financial measures” using accounting principles generally accepted in the United States (GAAP) and using adjustments to GAAP (non-GAAP). These non-GAAP measures are not measurements under GAAP. These measurements should be considered in addition to, but not as a substitute for, the information contained in our financial statements prepared in accordance with GAAP. We define EBITDA as net income (loss) adjusted for loss from discontinued operations, interest expense, income tax and depreciation and amortization. We define EBITDAR as EBITDA adjusted for rent expense.

Our measurements of EBITDA and EBITDAR may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA in this press release because we believe that such information is used by certain investors as measures of the Company’s historical performance. Our presentation of EBITDA should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

We have included EBITDAR in this press release because we believe that such information is used by certain investors as measures of the Company’s valuation. We believe that EBITDAR is an important financial valuation measure that is commonly used by our management, research analysts, investors, lenders and financial institutions, to compare the enterprise value of different companies in the healthcare industry, without regard to differences in capital structures and leasing arrangements. EBITDAR is a financial valuation measure and is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. As such, our presentation of EBITDAR, should not be construed as a financial performance measure.

DIVERSICARE HEALTHCARE SERVICES, INC. SELECTED OPERATING STATISTICS

(Unaudited)

Three Months Ended September 30, 2020

 

As of September 30, 2020

 

 

 

 

Occupancy (Note 2)

 

 

 

 

 

 

 

 

Region (Note 1)

Licensed Nursing Beds Note (4)

 

Available Nursing Beds Note (4)

 

Skilled Nursing Weighted Average Daily Census

 

Licensed Nursing Beds

 

Available Nursing Beds

 

Medicare Utilization

 

2020 Q3 Revenue ($ in millions)

 

Medicare Room and Board Revenue PPD (Note 3)

 

Medicaid Room and Board Revenue PPD (Note 3)

Alabama

2,464

2,397

1,797

72.9

%

75.0

%

11.2

%

$

43.0

$

488.27

$

189.44

Kansas

464

464

340

73.3

%

73.3

%

12.0

%

 

7.8

 

509.58

 

178.74

Mississippi

1,039

1,004

753

72.5

%

75.0

%

13.6

%

 

17.4

 

474.47

 

197.51

Missouri

339

339

214

63.1

%

63.1

%

14.0

%

 

4.9

 

546.03

 

145.53

Ohio

403

393

396

98.1

%

100.6

%

11.2

%

 

8.7

 

379.37

 

164.44

Tennessee

775

709

436

56.3

%

61.5

%

15.2

%

 

14.2

 

585.03

 

237.31

Texas

1,845

1,662

954

51.7

%

57.4

%

9.0

%

 

22.0

 

558.83

 

154.57

Total

7,329

6,968

4,890

66.7

%

70.2

%

11.7

%

$

118.0

$

503.75

$

183.27

 

 

 

 

 

 

 

 

 

 

Note 1:

The Alabama region includes nursing centers in Alabama and Florida. The Tennessee region includes one nursing center in Indiana.

Note 2:

The number of Licensed Nursing Beds is based on the licensed capacity of the facility. The Company has historically reported its occupancy based on licensed nursing beds, and excludes a limited number of assisted living, independent living, and personal care beds. The number of Available Nursing Beds represents licensed nursing beds less beds removed from service. Available nursing beds is subject to change based upon the needs of the facilities, including configuration of patient rooms, common usage areas and offices, status of beds (private, semi-private, ward, etc.) and renovations. Occupancy is measured on a weighted average basis.

Note 3:

These Medicare and Medicaid revenue rates include room and board revenues, but do not include any ancillary revenues related to these patients nor the Medicaid related stimulus of $6.6 million and Medicare related stimulus of $9.6 recognized during 2020 Q3.

Note 4:

The Licensed and Available Nursing Bed counts above include only licensed and available SNF beds.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20201105006149/en/

Company Contact: James R. McKnight, Jr. Chief Executive Officer 615-771-7575

Investor Relations: Kerry D. Massey Chief Financial Officer 615-771-7575